Larvol Delta - Ceruvia-Lifesciences-Submits-FDA-Investigational-New-Drug-Application-for-NYPRG101-Migraine-Prevention-Program

2-bromo-D-lysergic acid diethylamide (NYPRG-101) - Ceruvia Lifesci

https://www.prnewswire.com/news-releases/neuritest-presented-publicly-for-the-first-time-at-the-international-society-for-stem-cell-research-annual-meeting-301572669.html

Jun 22, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev